Transcatheter embolisation in urology: Difference between revisions
No edit summary |
Created page with "<section begin="urology" />In urology, transcatheter embolisation is used on the following indications: * To embolise arteriovenous fistulas and arteriovenous malformations in the renal arteries * Stop severe bleeding from the urinary system, for example from the kidney, bladder, or pelvis * Pre- or postoperatively for renal cell carcinoma in very large or highly vascularised tumours * To induce renal infarcti..." |
||
| Line 5: | Line 5: | ||
* Pre- or postoperatively for renal cell carcinoma in very large or highly vascularised tumours | * Pre- or postoperatively for renal cell carcinoma in very large or highly vascularised tumours | ||
* To induce renal infarction and thereby reducing kidney function, in case of severe [[nephrotic syndrome]] or in case of [[end-stage kidney failure]] and [[hypertension]] | * To induce renal infarction and thereby reducing kidney function, in case of severe [[nephrotic syndrome]] or in case of [[end-stage kidney failure]] and [[hypertension]] | ||
<section end="urology" /> | <section end="urology" /> | ||
[[Category:Urology]] | [[Category:Urology]] | ||
Revision as of 09:57, 16 September 2024
In urology, transcatheter embolisation is used on the following indications:
- To embolise arteriovenous fistulas and arteriovenous malformations in the renal arteries
- Stop severe bleeding from the urinary system, for example from the kidney, bladder, or pelvis
- Pre- or postoperatively for renal cell carcinoma in very large or highly vascularised tumours
- To induce renal infarction and thereby reducing kidney function, in case of severe nephrotic syndrome or in case of end-stage kidney failure and hypertension